Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy (Q41553914)

3 October 2017

title

Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy (English)

1 reference

3 October 2017

1 reference

Rita Rinaldi

13

0 references

Vladimiro Pietrini

Vladimiro Pietrini

11

0 references

Jessica Mandrioli

Jessica Mandrioli

1

0 references

Enrico Granieri

Enrico Granieri

17

0 references

Rocco Liguori

Rocco Liguori

9

0 references

author name string

Sara Biguzzi

2

1 reference

3 October 2017

Carlo Guidi

3

1 reference

3 October 2017

Elisabetta Sette

4

1 reference

3 October 2017

Emilio Terlizzi

5

1 reference

3 October 2017

Alessandro Ravasio

6

1 reference

3 October 2017

Mario Casmiro

7

1 reference

3 October 2017

Fabrizio Salvi

8

1 reference

3 October 2017

Romana Rizzi

10

1 reference

3 October 2017

Annamaria Borghi

12

1 reference

3 October 2017

Nicola Fini

14

1 reference

3 October 2017

Elisabetta Chierici

15

1 reference

3 October 2017

Mario Santangelo

16

1 reference

3 October 2017

Vittoria Mussuto

18

1 reference

3 October 2017

Silvia De Pasqua

19

1 reference

3 October 2017

Eleni Georgoulopoulou

20

1 reference

3 October 2017

Antonio Fasano

21

1 reference

3 October 2017

ERRALS Group

22

1 reference

3 October 2017

Salvatore Ferro

23

1 reference

3 October 2017

Roberto D'Alessandro

24

1 reference

3 October 2017

publication date

24 July 2015

1 reference

3 October 2017

published in

Neurological Sciences

1 reference

3 October 2017

volume

36

1 reference

3 October 2017

issue

12

1 reference

3 October 2017

page(s)

2243-2252

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-015-2343-6

3 October 2017

exact match

0 references

cites work

Clinical diagnosis and management of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

The ALSFRSr predicts survival time in an ALS clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Progression in ALS is not linear but is curvilinear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Amyotrophic lateral sclerosis disease progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Prognostic factors for the course of functional status of patients with ALS: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Outcome measures for early phase clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Disease progression in amyotrophic lateral sclerosis: predictors of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Clinical significance in the change of decline in ALSFRS-R

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Measuring function in advanced ALS: validation of ALSFRS-EX extension items

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Inter-evaluator reliability of the ALS Functional Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2343-6

Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis

21 January 2018

1 reference

12 December 2020

Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study

1 reference

12 December 2020

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group

1 reference

12 December 2020

A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements.

1 reference

12 December 2020

ALS clinical trials: Do enrolled patients accurately represent the ALS population?

1 reference

12 December 2020

10.1007/S10072-015-2343-6

Identifiers

DOI

1 reference

3 October 2017

1 reference